Company Search:
Advanced Search
Sponsored Links
Enzymatica AB (publ) Company Snapshot
Enzymatica AB (publ) operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Enzymatica AB (publ) with three other pharmaceutical manufacturers in Europe: Camurus AB (2017 sales of 54.31 million Swedish Kronor [US$5.98 million] of which 100% was Products & Services), Paion AG of Germany (5.81 million Euro [US$6.59 million] of which 100% was Pharmaceutical), and Norda ASA which is based in Norway (62.38 million Norwegian Kroner [US$7.39 million] ).

Sales Analysis. During the year ended December of 2017, sales at Enzymatica AB (publ) were SEK 59.45 million (US$6.55 million). This is an increase of 62.9% versus 2016, when the company's sales were SEK 36.48 million. This was the fifth consecutive year of sales increases at Enzymatica AB (publ) (and since 2012, sales have increased a total of 6,542%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Enzymatica AB (publ)
  Stock Performance Chart for Enzymatica AB (publ)
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 2.00
(Figures in Swedish Kronor)
1 Week -17.5%   13 Weeks -33.3%  
4 Weeks -29.1%   52 Weeks -40.6%  
Enzymatica AB (publ) Key Data:
  Ticker: ENZY Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 59,446,000
(Year Ending Jan 2018).
Employees: 21
  Currency: Swedish Kronor Market Cap: 186,744,514
  Fiscal Yr Ends: December Shares Outstanding: 93,372,257
  Share Type: Aktie Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.